|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$99
|
$269B |
4.2x |
9.1x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$191B |
3.1x |
7.7x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€81
|
$124B |
2.3x |
7.8x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$117B |
2.7x |
8.0x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 173
|
$65.3B |
4.1x |
12.1x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€237
|
$54.0B |
6.3x |
20.4x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$31
|
$8.2B |
4.2x |
-2.5x |
|
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$8.1B |
3.8x |
-48.5x |
|
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 46
|
$7.8B |
N/A |
N/A |
|
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 218
|
$7.6B |
7.7x |
25.2x |
|
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$220
|
$6.5B |
143175.2x |
N/A |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$92
|
$5.4B |
1.7x |
-4.4x |
|
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2582
|
$4.6B |
10.9x |
33.1x |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$43
|
$4.0B |
N/A |
N/A |
|
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 15
|
$3.4B |
5.1x |
14.3x |
|
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 45
|
$3.2B |
10.2x |
63.1x |
|
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 9026
|
$2.5B |
N/A |
N/A |
|
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 15
|
$2.4B |
5.9x |
21.9x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.4B |
22.0x |
N/A |
|
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 11
|
$2.3B |
6.6x |
23.1x |
|
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 51300
|
$2.3B |
5.4x |
-80.3x |
|
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 15
|
$2.2B |
12.4x |
52.9x |
|
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 50
|
$2.1B |
8.5x |
-708.1x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$22
|
$2.0B |
8.3x |
-5.6x |
|
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 183
|
$1.8B |
1.9x |
5.4x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$20
|
$1.5B |
197.4x |
-7.2x |
|
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 17056
|
$1.5B |
N/A |
N/A |
|
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€31
|
$1.4B |
N/A |
N/A |
|
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$1.4B |
8.6x |
9.4x |
|
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 76
|
$1.3B |
7.0x |
18.8x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$29
|
$1.2B |
456.8x |
-8.0x |
|
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$1.1B |
6.6x |
22.1x |
|
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$1.1B |
384.8x |
-4.4x |
|
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 13
|
$1.1B |
7.6x |
13.0x |
|
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$46
|
$1.0B |
5.1x |
-34.3x |
|
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 6
|
$1.0B |
32.4x |
-28.3x |
|
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$991M |
12.1x |
-30.3x |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$905M |
2.7x |
35.5x |
|
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 15
|
$849M |
5.4x |
10.9x |
|
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$844M |
16.7x |
-4.4x |
|
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$821M |
3.5x |
11.1x |
|
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$785M |
3.9x |
-16.3x |
|
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 4
|
$755M |
4.0x |
N/A |
|
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$45
|
$746M |
16.6x |
-5.1x |
|
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$724M |
23297.5x |
N/A |
|
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 23
|
$563M |
531.9x |
-28.7x |
|
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$558M |
6.6x |
-58.3x |
|
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$549M |
11.0x |
-9.1x |
|
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$7
|
$549M |
0.5x |
1.5x |
|
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$521M |
N/A |
N/A |
|
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 6
|
$510M |
N/A |
N/A |
|
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$507M |
422.6x |
-1.6x |
|
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 400
|
$505M |
N/A |
N/A |
|
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$4
|
$478M |
5.4x |
-5.0x |
|
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$463M |
N/A |
N/A |
|
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$447M |
19.7x |
-0.9x |
|
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 5
|
$445M |
N/A |
-7.1x |
|
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$442M |
88.2x |
N/A |
|
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$33
|
$418M |
17522.2x |
-2.4x |
|
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 384
|
$413M |
1.9x |
N/A |
|
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 38
|
$352M |
18.1x |
-1220.1x |
|
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 23
|
$350M |
1.9x |
8.0x |
|
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 19
|
$306M |
N/A |
N/A |
|
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$298M |
N/A |
-11.6x |
|
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 24
|
$291M |
1.5x |
7.0x |
|
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$283M |
N/A |
-1.7x |
|
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$255M |
9748519.7x |
-9.4x |
|
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$236M |
N/A |
-5.2x |
|
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$182M |
N/A |
N/A |
|
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$165M |
1.1x |
N/A |
|
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$165M |
5.0x |
N/A |
|
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$163M |
15.0x |
-4.2x |
|
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$145M |
N/A |
N/A |
|
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$144M |
53111.9x |
-0.7x |
|
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 10030
|
$142M |
N/A |
N/A |
|
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$141M |
46.8x |
-7.5x |
|
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 16
|
$138M |
N/A |
N/A |
|
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$138M |
1398.5x |
N/A |
|
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$138M |
483348.7x |
-5.5x |
|
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$130M |
N/A |
N/A |
|
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$17
|
$128M |
1.0x |
3.7x |
|
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 16
|
$126M |
N/A |
N/A |
|
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 29
|
$125M |
N/A |
N/A |
|
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€5
|
$122M |
2.4x |
-141.9x |
|
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$2
|
$119M |
1.6x |
-0.5x |
|
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$1
|
$104M |
N/A |
N/A |
|
Shattuck Labs
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$103M |
75.8x |
-2.1x |
|
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$101M |
N/A |
-4.1x |
|
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$91.7M |
N/A |
N/A |
|
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$91.6M |
N/A |
N/A |
|
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$90.1M |
N/A |
-0.5x |
|
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$89.3M |
15.3x |
N/A |
|
SAB Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$83.8M |
1779.8x |
N/A |
|
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$79.9M |
N/A |
N/A |
|
Prescient Therapeutics
|
Australia |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
AUD 0
|
$64.4M |
N/A |
N/A |
|
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$62.4M |
19.0x |
N/A |
|
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$60.7M |
19.5x |
-1.7x |
|
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$60.4M |
7.6x |
N/A |
|
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$59.9M |
N/A |
N/A |
|
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$54.0M |
N/A |
N/A |